Next Article in Journal
Using a Chemical Genetic Screen to Enhance Our Understanding of the Antibacterial Properties of Silver
Next Article in Special Issue
Evolutionary Divergent Suppressor Mutations in Conformational Diseases
Previous Article in Journal
Gene Regulatory Networks Reconstruction Using the Flooding-Pruning Hill-Climbing Algorithm
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessArticle
Genes 2018, 9(7), 343;

Epistatic Interactions in NS5A of Hepatitis C Virus Suggest Drug Resistance Mechanisms

Institute of Virology, University of Cologne, 50935 Cologne, Germany
German Center for Infection Research (DZIF)—Cologne-Bonn Partner Site, 50935 Cologne, Germany
Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, 66123 Saarbrücken, Germany
German Center for Infection Research (DZIF)—Saarbrücken Partner Site, 66123 Saarbrücken, Germany
Author to whom correspondence should be addressed.
Received: 27 March 2018 / Accepted: 29 June 2018 / Published: 6 July 2018
(This article belongs to the Special Issue Evolution and Structure of Proteins and Proteomes)
Full-Text   |   PDF [1235 KB, uploaded 6 July 2018]   |  


Hepatitis C virus (HCV) causes a major health burden and can be effectively treated by direct-acting antivirals (DAAs). The non-structural protein 5A (NS5A), which plays a role in the viral genome replication, is one of the DAAs’ targets. Resistance-associated viruses (RAVs) harbouring NS5A resistance-associated mutations (RAMs) have been described at baseline and after therapy failure. A mutation from glutamine to arginine at position 30 (Q30R) is a characteristic RAM for the HCV sub/genotype (GT) 1a, but arginine corresponds to the wild type in the GT-1b; still, GT-1b strains are susceptible to NS5A-inhibitors. In this study, we show that GT-1b strains with R30Q often display other specific NS5A substitutions, particularly in positions 24 and 34. We demonstrate that in GT-1b secondary substitutions usually happen after initial R30Q development in the phylogeny, and that the chemical properties of the corresponding amino acids serve to restore the positive charge in this region, acting as compensatory mutations. These findings may have implications for RAVs treatment. View Full-Text
Keywords: hepatitis C virus; NS5A; drug resistance; epistasis; protein structure hepatitis C virus; NS5A; drug resistance; epistasis; protein structure

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Knops, E.; Sierra, S.; Kalaghatgi, P.; Heger, E.; Kaiser, R.; Kalinina, O.V. Epistatic Interactions in NS5A of Hepatitis C Virus Suggest Drug Resistance Mechanisms. Genes 2018, 9, 343.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Genes EISSN 2073-4425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top